Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 27, 2024 04:28 ET | Source: Research and Markets

Schizophrenia Drug Market Forecast to 2031: The Entry of Adjunctive Therapies to Shape the Schizophrenia Market

Dublin, Dec. 27, 2024 (GLOBE NEWSWIRE) -- The "Schizophrenia: Seven-Market Drug Forecast and Market Analysis - Update" report has been added to ResearchAndMarkets.com's offering.This report covers...
January 22, 2024 12:18 ET | Source: Research and Markets

Major Depressive Disorder: New Insight-Focused Report Forecasts a Landscape Shifting 2019-2029

Dublin, Jan. 22, 2024 (GLOBE NEWSWIRE) -- The "Major Depressive Disorder - Eight-Market Drug Forecast and Market Analysis - Update" report has been added to ResearchAndMarkets.com's offering. A...
April 19, 2021 07:58 ET | Source: Research and Markets

Global Major Depressive Disorder (MDD) Drug Market Report 2021: Therapeutics Market Will Grow to $7.9B by 2029

Dublin, April 19, 2021 (GLOBE NEWSWIRE) -- The "Major Depressive Disorder - Global Drug Forecast and Market Analysis to 2029" report has been added to ResearchAndMarkets.com's offering. The MDD...
April 16, 2009 10:17 ET | Source: Cutting Edge Information

Cutting Edge Information Analyzes the Bristol-Myers Squibb / Otsuka Pharma Profit-Sharing Strategy for 2010 and Beyond

RESEARCH TRIANGLE PARK, NC--(Marketwire - April 16, 2009) - The recently announced deal between Bristol-Myers Squibb and Otsuka over Abilify will go a long way toward shoring up both companies'...